Rationale and design of the RIACT–study: a multi-center placebo controlled double blind study to test the efficacy of RItuximab in Acute Cellular tubulointerstitial rejection with B-cell infiltrates in renal Transplant patients: study protocol for a randomized controlled trial

Schiffer, Lena; Schiffer, Mario; Merkel, Saskia; Schwarz, Anke; Mengel, Michael; Jürgens, Christopher; Schroeder, Christoph; Zoerner, Alexander A; Püllmann, Kerstin; Bröcker, Verena; Becker, Jan U; Dämmrich, Maximilian E; Träder, Jana; Großhennig, Anika; Biertz, Frank; Haller, Hermann; Koch, Armin; Gwinner, Wilfried

doi:10.1186/1745-6215-13-199

Trials

Article metrics
Last updated: Wed, 24 Apr 2024 9:00:42 Z

Rationale and design of the RIACT–study: a multi-center placebo controlled double blind study to test the efficacy of RItuximab in Acute Cellular tubulointerstitial rejection with B-cell infiltrates in renal Transplant patients: study protocol for a randomized controlled trial

Access & Citations

3785

Article Accesses
2

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1745-6215

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com